Log on / register
Feedback | Support | My details
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors.
Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu Z, Rasmussen KE, Jones LP, Assefnia S, Chandrasekharan S, Backlund MG, Yin Y, Khramtsov AI, Bastein R, Quackenbush J, Glazer RI, Brown PH, Green JE, Kopelovich L, Furth PA, Palazzo JP, Olopade OI, Bernard PS, Churchill GA, Van Dyke T, Perou CM
Genome Biol 2007, 8:R76
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
ID genes mediate tumor reinitiation during breast cancer lung metastasis.
Gupta GP, Perk J, Acharyya S, de Candia P, Mittal V, Todorova-Manova K, Gerald WL, Brogi E, Benezra R, Massagué J
Proc Natl Acad Sci U S A 2007 Dec 4, 104:19506-11
[PubMed Central] [PubMed] [Related articles]

2.
ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complex.
Li Z, Tognon CE, Godinho FJ, Yasaitis L, Hock H, Herschkowitz JI, Lannon CL, Cho E, Kim SJ, Bronson RT, Perou CM, Sorensen PH, Orkin SH
Cancer Cell 2007 Dec, 12:542-58
[PubMed Central] [PubMed] [Related articles]

3.
Comparison of expression profiles of metastatic versus primary mammary tumors in MMTV-Wnt-1 and MMTV-Neu transgenic mice.
Huang S, Chen Y, Podsypanina K, Li Y
Neoplasia 2008 Feb, 10:118-24
[PubMed Central] [PubMed] [Related articles]

4.
GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model.
Kouros-Mehr H, Bechis SK, Slorach EM, Littlepage LE, Egeblad M, Ewald AJ, Pai SY, Ho IC, Werb Z
Cancer Cell 2008 Feb, 13:141-52
[PubMed Central] [PubMed] [Related articles]

5.
Id1 cooperates with oncogenic Ras to induce metastatic mammary carcinoma by subversion of the cellular senescence response.
Swarbrick A, Roy E, Allen T, Bishop JM
Proc Natl Acad Sci U S A 2008 Apr 8, 105:5402-7
[PubMed Central] [PubMed] [Related articles]

6.
The rexinoid, bexarotene, prevents the development of premalignant lesions in MMTV-erbB2 mice.
Li Y, Zhang Y, Hill J, Kim HT, Shen Q, Bissonnette RP, Lamph WW, Brown PH
Br J Cancer 2008 Apr 22, 98:1380-8
[PubMed Central] [PubMed] [Related articles]

7.
Identification of tumor-initiating cells in a p53-null mouse model of breast cancer.
Zhang M, Behbod F, Atkinson RL, Landis MD, Kittrell F, Edwards D, Medina D, Tsimelzon A, Hilsenbeck S, Green JE, Michalowska AM, Rosen JM
Cancer Res 2008 Jun 15, 68:4674-82
[PubMed Central] [PubMed] [Related articles]

8.
Molecular credentialing of rodent bladder carcinogenesis models.
Williams PD, Lee JK, Theodorescu D
Neoplasia 2008 Aug, 10:838-46
[PubMed Central] [PubMed] [Related articles]

9.
Matrix metalloproteinase 13 is induced in fibroblasts in polyomavirus middle T antigen-driven mammary carcinoma without influencing tumor progression.
Nielsen BS, Egeblad M, Rank F, Askautrud HA, Pennington CJ, Pedersen TX, Christensen IJ, Edwards DR, Werb Z, Lund LR
PLoS One 2008, 3:e2959
[PubMed Central] [PubMed] [Related articles]

10.
Visualizing stromal cell dynamics in different tumor microenvironments by spinning disk confocal microscopy.
Egeblad M, Ewald AJ, Askautrud HA, Truitt ML, Welm BE, Bainbridge E, Peeters G, Krummel MF, Werb Z
Dis Model Mech 2008 Sep-Oct, 1:155-67; discussion 165
[PubMed Central] [PubMed] [Related articles]

11.
*** Unable to retrieve article 19048079 ***

[PubMed Central] [PubMed] [Related articles]

12.
Genetic mechanisms in Apc-mediated mammary tumorigenesis.
Kuraguchi M, Ohene-Baah NY, Sonkin D, Bronson RT, Kucherlapati R
PLoS Genet 2009 Feb, 5:e1000367
[PubMed Central] [PubMed] [Related articles]

13.
Molecular profiles of progesterone receptor loss in human breast tumors.
Creighton CJ, Kent Osborne C, van de Vijver MJ, Foekens JA, Klijn JG, Horlings HM, Nuyten D, Wang Y, Zhang Y, Chamness GC, Hilsenbeck SG, Lee AV, Schiff R
Breast Cancer Res Treat 2009 Mar, 114:287-99
[PubMed Central] [PubMed] [Related articles]

14.
Igf1r as a therapeutic target in a mouse model of basal-like breast cancer.
Klinakis A, Szabolcs M, Chen G, Xuan S, Hibshoosh H, Efstratiadis A
Proc Natl Acad Sci U S A 2009 Feb 17, 106:2359-64
[PubMed Central] [PubMed] [Related articles]

15.
The Wnt co-receptor Lrp6 is required for normal mouse mammary gland development.
Lindvall C, Zylstra CR, Evans N, West RA, Dykema K, Furge KA, Williams BO
PLoS One 2009, 4:e5813
[PubMed Central] [PubMed] [Related articles]

16.
Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?
Tan AR, Alexe G, Reiss M
Breast Cancer Res Treat 2009 Jun, 115:453-95
[PubMed Central] [PubMed] [Related articles]

17.
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features.
Creighton CJ, Li X, Landis M, Dixon JM, Neumeister VM, Sjolund A, Rimm DL, Wong H, Rodriguez A, Herschkowitz JI, Fan C, Zhang X, He X, Pavlick A, Gutierrez MC, Renshaw L, Larionov AA, Faratian D, Hilsenbeck SG, Perou CM, Lewis MT, Rosen JM, Chang JC
Proc Natl Acad Sci U S A 2009 Aug 18, 106:13820-5
[PubMed Central] [PubMed] [Related articles]

18.
The Wnt receptor, Lrp5, is expressed by mouse mammary stem cells and is required to maintain the basal lineage.
Badders NM, Goel S, Clark RJ, Klos KS, Kim S, Bafico A, Lindvall C, Williams BO, Alexander CM
PLoS One 2009, 4:e6594
[PubMed Central] [PubMed] [Related articles]

19.
Phosphatase and tensin homologue deleted on chromosome 10 deficiency accelerates tumor induction in a mouse model of ErbB-2 mammary tumorigenesis.
Dourdin N, Schade B, Lesurf R, Hallett M, Munn RJ, Cardiff RD, Muller WJ
Cancer Res 2008 Apr 1, 68:2122-31
[PubMed Central] [PubMed] [Related articles]

20.
Collective epithelial migration and cell rearrangements drive mammary branching morphogenesis.
Ewald AJ, Brenot A, Duong M, Chan BS, Werb Z
Dev Cell 2008 Apr, 14:570-81
[PubMed Central] [PubMed] [Related articles]


This article is also cited by 11 articles in BioMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]

© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.